MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations
Ferdinando D’Amico, Francesca Lusetti, Laurent Peyrin‐Biroulet, Silvio Danese
Topics & Concepts
MedicineMMXUlcerative colitisInternal medicineProdrugGastroenterologyHepatologyClinical trialColitisClinical PracticeAdverse effectClinical efficacyPharmacologyDiseasePhysical therapyComputer scienceOperating systemInflammatory Bowel DiseaseMicroscopic ColitisPregnancy and Medication Impact